Molecular Diagnostics
Germline Risk Variants Found in Prostate Cancer Patients
Studies done over the past five years or so have unearthed pathogenic germline variants in some 12% to 17% of men with prostate cancer, and such alterations can impact everything from the treatment options available to them, to the management strategies used for other members of the same family. More...21 May 2020
Non-Invasive Blood Assay Can Detect Early Colorectal Cancer
Colorectal cancer (CRC), also known as bowel cancer, colon cancer, or rectal cancer, is the development of cancer from the colon or rectum (parts of the large intestine). In general, colon cancer begins when healthy cells in the colon develop changes (mutations) in their DNA and as the cells accumulate, they form a tumor. More...21 May 2020
New Blood Test Can Determine When an Individual Was Exposed to a Pathogenic Microorganism
An international research team has developed a diagnostic blood test – initially for the recurring form of vivax malaria – that can determine when an individual was exposed to a pathogenic microorganism, including the coronavirus that causes COVID-19. More...19 May 2020
Rare Kidney Cancer Marked by Molecular Features
Renal medullary carcinoma is a rare cancer of the kidney that predominantly afflicts young people of African descent who carry the sickle cell trait, sickle cell disease, or other sickle hemoglobinopathies that can cause sickling of the red blood cells. More...19 May 2020
Higher Concentrations of COVID-19 Receptor Protein Found in Men’s Plasma
Results of a large-scale study revealed that plasma concentrations of angiotensin-converting enzyme 2 (ACE2) were higher in men than in women, but use of neither an ACE inhibitor nor an angiotensin receptor blocker (ARB) was associated with higher plasma ACE2 concentrations. More...18 May 2020
Gold Member
Collection and Transport System
PurSafe Plus®
New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
Urine Chemistry Control
Dropper Urine Chemistry Control
In Other News
Blood Test Shows Promise for Predicting Cancer
Knowing the Ethnic Specificity of Urinary Biomarker Proteins Could Refine Diagnosis of Lupus Nephritis
Biomarker Panel Predicts Severity of Pollen Allergy Symptoms
Multicancer Blood Test Aids Screen for Cancer Guide Intervention
CRISPR-Based Microarray System Enables Massive Testing for Viral Pathogens
A Series of Sensitive and Specific DNA-Based Assays Detects and Differentiates Salmonella Serotypes
Targeted Next-Generation Sequencing Validated for Lysosomal Storage Disorders Diagnosis
Phosphorylated Tau Protein Blood Test Distinguishes Alzheimer’s Disease from Other Neurological Disorders
Rapid Diagnostic Sensor Detects COVID-19 Directly from Swab Extracts
Proteomic Analysis of Urinary Extracellular Vesicles for the Diagnosis of Prostate Cancer
Liquid Biopsy Assay for the Early Detection of Pancreatic Cancer
Scabies Detected by Molecular Methods in Skin Scrapings
Genetic Alterations Analyzed in Pediatric Low-Grade Glioma
Molecular Differences Discovered Among Ovarian Cancer Subgroups
Human NK Cells Identified by Single-Cell RNA Sequencing
Important Genetic Mechanism Behind Inflammatory Bowel Disease Revealed
Acetylated Tubulin Is a Biomarker for Severe Depression
Missing BAP1 Gene Associated with Immunosuppressive Molecules in Uveal Melanoma
Large Proteomics Study Identifies New Fluid Biomarkers for Diagnosis of Alzheimer’s Disease
A Non-Invasive Urine Test for Prediction of Kidney Transplant Failure
Real-Time Assay Evaluated for Two Sexually Transmitted Diseases
RT-LAMP Assay Developed for SARS-CoV-2
Genetic Risk Score Predicts Prostate Cancer Drug Response
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.